These compounds may interact with:
Perilipin-1
Potentially involved in: familial partial lipodystrophy; carcinoma; obesity; neutral lipid storage disease; lipodystrophy; diabetes mellitus; fatty liver disease; urethral calculus; amyotrophic lateral sclerosis type 20; tarsal tunnel syndrome; acanthosis nigricans; hyperinsulinism; hypertensive disease; infertility; oligomenorrhea; polycystic ovary syndrome; fibrosis, liver; increase in blood pressure; sclerocystic ovaries; lipoatrophy
Disease data sourced from Pharos.